Guardant Health, Inc. (GH): Price and Financial Metrics
Guardant Health, Inc. (GH)
Today's Latest Price: $157.30 USD
Updated Jan 25 6:55pm
Add GH to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 188 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
GH Stock Summary
- Guardant Health Inc's stock had its IPO on October 4, 2018, making it an older stock than just 5.26% of US equities in our set.
- With a price/sales ratio of 58.93, Guardant Health Inc has a higher such ratio than 94.9% of stocks in our set.
- With a year-over-year growth in debt of 28,864.96%, Guardant Health Inc's debt growth rate surpasses 99.79% of about US stocks.
- If you're looking for stocks that are quantitatively similar to Guardant Health Inc, a group of peers worth examining would be LASR, MDLA, WORK, TNDM, and PFPT.
- GH's SEC filings can be seen here. And to visit Guardant Health Inc's official web site, go to guardanthealth.com.
GH Stock Price Chart Interactive Chart >
GH Price/Volume Stats
| Current price | $157.30 | 52-week high | $168.52 |
| Prev. close | $159.92 | 52-week low | $55.90 |
| Day low | $152.06 | Volume | 877,500 |
| Day high | $163.21 | Avg. volume | 1,229,487 |
| 50-day MA | $130.02 | Dividend yield | N/A |
| 200-day MA | $100.83 | Market Cap | 15.73B |
Guardant Health, Inc. (GH) Company Bio
Guardant Health, Inc., a precision oncology company, provides non-invasive cancer diagnostics. It offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes from circulating tumor DNA (ctDNA); and GuardantOMNI, a broader panel measuring various genes from ctDNA. The company also provides LUNAR-1 for recurrence detection in cancer survivors; and LUNAR-2 for early detection of cancer in higher risk individuals. Guardant Health, Inc. was founded in 2011 and is based in Redwood City, California.
Loading social stream, please wait...